Withdrawal of Approval of Drug Application: TG Therapeutics, Inc.; Ukoniq (Umbralisib Tosylate) Tablets, Equivalent to 200 Milligrams Base

TitleWithdrawal of Approval of Drug Application: TG Therapeutics, Inc.; Ukoniq (Umbralisib Tosylate) Tablets, Equivalent to 200 Milligrams Base
ToC Doc TG Therapeutics, Inc.; Ukoniq (Umbralisib Tosylate) Tablets, Equivalent to 200 Milligrams Base
Docket Number2022-11631
Type Notice
Subject Withdrawal of Approval of Drug Application:
TG Therapeutics, Inc.; Ukoniq (Umbralisib Tosylate) Tablets, Equivalent to 200 Milligrams Base
Publication Date2022-05-31
Last Updated Date 2022-05-27 08:15:09 -0400
Last Public Inspection2022-05-27
Filed At2022-05-27T08:45:00.000-04:00
PDF 2022-11631_PI.pdf (96123 bytes)
Download TXT / HTML / JSON
Number of Pages 3
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021